Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
multivalent gonorrhea vaccine
- Development stage
- Unknown
- Lead developer
- LimmaTech Biologics
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The multivalent gonorrhea vaccine is a bioconjugate vaccine candidate developed by LimmaTech Biologics AG for the prevention of infections caused by *Neisseria gonorrhoeae*. The vaccine is produced using LimmaTech's proprietary bioconjugation technology, which enzymatically links bacterial surface antigens to carrier proteins to induce a robust and broad immune response. By targeting multiple antigens, the vaccine aims to provide protection against a wide range of *N. gonorrhoeae* strains, including those that are multi-drug resistant (MDR). The program has received support from CARB-X and is currently being evaluated in Phase I clinical trials to assess its safety, tolerability, and immunogenicity in healthy volunteers.
- Other names
- gonorrhea vaccineNeisseria gonorrhoeae vaccinebioconjugate gonorrhea vaccine
Beyond the preview
Go deeper on multivalent gonorrhea vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on multivalent gonorrhea vaccine.